ABC - AmerisourceBergen to expand biopharma services platform with Euro1.28B PharmaLex acquisition

• AmerisourceBergen ( NYSE: ABC ) on Monday said it would acquire PharmaLex Holding GmbH, a provider of specialized services for the life sciences industry, for €1.28B in cash.
• PharmaLex would be acquired from funds advised by AUCTUS Capital Partners AG and the deal would be subject to certain customary adjustments, ABC said in a statement .
• ABC expects the deal, upon closing, to be about $0.15 accretive to its adj. EPS for the last seven months of its fiscal year 2023.
• The deal will expands ABC's global platform of biopharmaceutical services, and PharmaLex's results will be reported as a component within ABC's international healthcare solutions segment.
• ABC stock closed -0.2% at $147.27 on Friday.

For further details see: